117 related articles for article (PubMed ID: 12869569)
1. Development of new insulin-like growth factor-1 receptor kinase inhibitors using catechol mimics.
Blum G; Gazit A; Levitzki A
J Biol Chem; 2003 Oct; 278(42):40442-54. PubMed ID: 12869569
[TBL] [Abstract][Full Text] [Related]
2. Substrate competitive inhibitors of IGF-1 receptor kinase.
Blum G; Gazit A; Levitzki A
Biochemistry; 2000 Dec; 39(51):15705-12. PubMed ID: 11123895
[TBL] [Abstract][Full Text] [Related]
3. ATP non-competitive IGF-1 receptor kinase inhibitors as lead anti-neoplastic and anti-papilloma agents.
Steiner L; Blum G; Friedmann Y; Levitzki A
Eur J Pharmacol; 2007 May; 562(1-2):1-11. PubMed ID: 17376430
[TBL] [Abstract][Full Text] [Related]
4. Discovery of an inhibitor of insulin-like growth factor 1 receptor activation: implications for cellular potency and selectivity over insulin receptor.
Wood ER; Shewchuk L; Hassel A; Nichols J; Truesdale AT; Smith D; Carter HL; Weaver K; Barrett G; Leesnitzer T; Alvarez E; Bardera AI; Alamillo A; Cantizani J; Martin J; Smith GK; Jensen DE; Xie H; Mook R; Kumar R; Kuntz K
Biochem Pharmacol; 2009 Dec; 78(12):1438-47. PubMed ID: 19665448
[TBL] [Abstract][Full Text] [Related]
5. Tumor-targeted Nanobullets: Anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment.
van der Meel R; Oliveira S; Altintas I; Haselberg R; van der Veeken J; Roovers RC; van Bergen en Henegouwen PM; Storm G; Hennink WE; Schiffelers RM; Kok RJ
J Control Release; 2012 Apr; 159(2):281-9. PubMed ID: 22227023
[TBL] [Abstract][Full Text] [Related]
6. Compounds from the marine sponge Cribrochalina vasculum offer a way to target IGF-1R mediated signaling in tumor cells.
Zovko A; Novak M; Hååg P; Kovalerchick D; Holmlund T; Färnegårdh K; Ilan M; Carmeli S; Lewensohn R; Viktorsson K
Oncotarget; 2016 Aug; 7(31):50258-50276. PubMed ID: 27384680
[TBL] [Abstract][Full Text] [Related]
7. Involvement of insulin-like growth factor type 1 receptor and protein kinase Cdelta in bis(maltolato)oxovanadium(IV)-induced phosphorylation of protein kinase B in HepG2 cells.
Mehdi MZ; Vardatsikos G; Pandey SK; Srivastava AK
Biochemistry; 2006 Sep; 45(38):11605-15. PubMed ID: 16981720
[TBL] [Abstract][Full Text] [Related]
8. Screening for small molecule inhibitors of insulin-like growth factor receptor (IGF-1R) kinase: comparison of homogeneous time-resolved fluorescence and 33P-ATP plate assay formats.
Wang Y; Malkowski M; Hailey J; Turek-Etienne T; Tripodi T; Pachter JA
J Exp Ther Oncol; 2004 Jul; 4(2):111-9. PubMed ID: 15500006
[TBL] [Abstract][Full Text] [Related]
9. A highly selective dual insulin receptor (IR)/insulin-like growth factor 1 receptor (IGF-1R) inhibitor derived from an extracellular signal-regulated kinase (ERK) inhibitor.
Anastassiadis T; Duong-Ly KC; Deacon SW; Lafontant A; Ma H; Devarajan K; Dunbrack RL; Wu J; Peterson JR
J Biol Chem; 2013 Sep; 288(39):28068-77. PubMed ID: 23935097
[TBL] [Abstract][Full Text] [Related]
10. Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth.
Girnita A; Girnita L; del Prete F; Bartolazzi A; Larsson O; Axelson M
Cancer Res; 2004 Jan; 64(1):236-42. PubMed ID: 14729630
[TBL] [Abstract][Full Text] [Related]
11. Medicinal chemistry approaches to target the kinase activity of IGF-1R.
Garcia-Echeverria C
IDrugs; 2006 Jun; 9(6):415-9. PubMed ID: 16752311
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins.
Párrizas M; Gazit A; Levitzki A; Wertheimer E; LeRoith D
Endocrinology; 1997 Apr; 138(4):1427-33. PubMed ID: 9075698
[TBL] [Abstract][Full Text] [Related]
13. Secretion of Annexin II via activation of insulin receptor and insulin-like growth factor receptor.
Zhao WQ; Chen GH; Chen H; Pascale A; Ravindranath L; Quon MJ; Alkon DL
J Biol Chem; 2003 Feb; 278(6):4205-15. PubMed ID: 12431980
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine kinase activity of a chimeric insulin-like-growth-factor-1 receptor containing the insulin receptor C-terminal domain. Comparison with the tyrosine kinase activities of the insulin and insulin-like-growth-factor-1 receptors using a cell-free system.
Mothe I; Tartare S; Kowalski-Chauvel A; Kaliman P; Van Obberghen E; Ballotti R
Eur J Biochem; 1995 Mar; 228(3):842-8. PubMed ID: 7737184
[TBL] [Abstract][Full Text] [Related]
15. Comparison of three approaches for inhibiting insulin-like growth factor I receptor and their effects on NSCLC cell lines in vitro.
Cosaceanu D; Carapancea M; Alexandru O; Budiu R; Martinsson HS; Starborg M; Vrabete M; Kanter L; Lewensohn R; Dricu A
Growth Factors; 2007 Feb; 25(1):1-8. PubMed ID: 17454144
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation site-specific inhibition of platelet-derived growth factor beta-receptor autophosphorylation by the receptor blocking tyrphostin AG1296.
Kovalenko M; Rönnstrand L; Heldin CH; Loubtchenkov M; Gazit A; Levitzki A; Böhmer FD
Biochemistry; 1997 May; 36(21):6260-9. PubMed ID: 9174341
[TBL] [Abstract][Full Text] [Related]
17. Discovery and optimization of imidazo[1,2-a]pyridine inhibitors of insulin-like growth factor-1 receptor (IGF-1R).
Emmitte KA; Wilson BJ; Baum EW; Emerson HK; Kuntz KW; Nailor KE; Salovich JM; Smith SC; Cheung M; Gerding RM; Stevens KL; Uehling DE; Mook RA; Moorthy GS; Dickerson SH; Hassell AM; Leesnitzer MA; Shewchuk LM; Groy A; Rowand JL; Anderson K; Atkins CL; Yang J; Sabbatini P; Kumar R
Bioorg Med Chem Lett; 2009 Feb; 19(3):1004-8. PubMed ID: 19101143
[TBL] [Abstract][Full Text] [Related]
18. Small-molecule ATP-competitive dual IGF-1R and insulin receptor inhibitors: structural insights, chemical diversity and molecular evolution.
Jin M; Wang J; Buck E; Mulvihill MJ
Future Med Chem; 2012 Mar; 4(3):315-28. PubMed ID: 22393939
[TBL] [Abstract][Full Text] [Related]
19. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved.
Pandini G; Frasca F; Mineo R; Sciacca L; Vigneri R; Belfiore A
J Biol Chem; 2002 Oct; 277(42):39684-95. PubMed ID: 12138094
[TBL] [Abstract][Full Text] [Related]
20. Specific targeting of insulin-like growth factor 1 receptor signaling in human estrogen dependent breast cancer cell by a novel tyrosine-based benzoxazepine derivative.
Chakravarti B; Siddiqui JA; Dwivedi SK; Deshpande S; Samanta K; Bhatta RS; Panda G; Prabhakar YS; Konwar R; Sanyal S; Chattopadhyay N
Mol Cell Endocrinol; 2011 May; 338(1-2):68-78. PubMed ID: 21457754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
